LOS ANGELES CAPITAL MANAGEMENT LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$855,996
-36.8%
54,280
-22.1%
0.00%
-20.0%
Q2 2023$1,354,657
-36.0%
69,684
-6.6%
0.01%
-44.4%
Q1 2023$2,116,828
+71.3%
74,615
+76.5%
0.01%
+50.0%
Q4 2022$1,235,727
-19.1%
42,276
+23.0%
0.01%
-25.0%
Q2 2022$1,527,000
-28.9%
34,358
-20.8%
0.01%0.0%
Q1 2022$2,148,000
+8.4%
43,394
+11.5%
0.01%
+14.3%
Q4 2021$1,982,000
-8.7%
38,918
-0.1%
0.01%
-30.0%
Q3 2021$2,172,000
+18.8%
38,939
-8.8%
0.01%
+25.0%
Q2 2021$1,828,000
+148.0%
42,709
+141.9%
0.01%
+166.7%
Q1 2021$737,000
-20.0%
17,659
-10.7%
0.00%
-25.0%
Q4 2020$921,000
-43.2%
19,774
-48.2%
0.00%
-42.9%
Q3 2020$1,621,000
-26.2%
38,149
-16.7%
0.01%
-36.4%
Q2 2020$2,197,000
+48.7%
45,786
+42.6%
0.01%
+22.2%
Q1 2020$1,477,000
+16.0%
32,105
+51.5%
0.01%
+50.0%
Q4 2019$1,273,000
+6.2%
21,1950.0%0.01%0.0%
Q3 2019$1,199,000
+46.8%
21,195
+44.5%
0.01%
+50.0%
Q2 2019$817,000
+10.4%
14,6650.0%0.00%0.0%
Q1 2019$740,000
+25.2%
14,6650.0%0.00%0.0%
Q4 2018$591,000
-32.1%
14,665
+16.9%
0.00%
-20.0%
Q3 2018$870,00012,5500.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders